These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
292 related items for PubMed ID: 1664670
1. Antibody response to glycoprotein I in maternally immune pigs exposed to a mildly virulent strain of pseudorabies virus. van Oirschot JT, Daus F, Kimman TG, van Zaane D. Am J Vet Res; 1991 Nov; 52(11):1788-93. PubMed ID: 1664670 [Abstract] [Full Text] [Related]
3. High- and low-challenge exposure doses used to compare intranasal and intramuscular administration of pseudorabies virus vaccine in passively immune pigs. Arellano PE, Morrison RB, Molitor TW, Thawley DG. J Am Vet Med Assoc; 1992 Mar 01; 200(5):685-91. PubMed ID: 1314793 [Abstract] [Full Text] [Related]
4. Intranasal vaccination of pigs against pseudorabies: absence of vaccinal virus latency and failure to prevent latency of virulent virus. van Oirschot JT, Gielkens AL. Am J Vet Res; 1984 Oct 01; 45(10):2099-103. PubMed ID: 6093645 [Abstract] [Full Text] [Related]
6. Immune response of pigs inoculated with virulent pseudorabies virus and pigs inoculated with attenuated or inactivated pseudorabies virus vaccine before and after challenge exposure. Kelling CL, Staudinger WL, Rhodes MB. Am J Vet Res; 1982 Dec 01; 43(12):2114-20. PubMed ID: 6299139 [Abstract] [Full Text] [Related]
7. Evaluation in swine of a subunit vaccine against pseudorabies. Maes RK, Schutz JC. Am J Vet Res; 1983 Jan 01; 44(1):123-5. PubMed ID: 6297337 [Abstract] [Full Text] [Related]
9. Transmission of two pseudorabies virus strains that differ in virulence and virus excretion in groups of vaccinated pigs. Bouma A, De Jong MC, Kimman TG. Am J Vet Res; 1996 Jan 01; 57(1):43-7. PubMed ID: 8720236 [Abstract] [Full Text] [Related]
10. Vaccination against pseudorabies with glycoprotein gI+ or glycoprotein gI- vaccine. Vandeputte J, Chappuis G, Fargeaud D, Précausta P, Guillemin F, Brun A, Desmettre P, Stellmann C. Am J Vet Res; 1990 Jul 01; 51(7):1100-6. PubMed ID: 2167620 [Abstract] [Full Text] [Related]
12. Field trial to evaluate the immunogenicity of pseudorabies virus vaccines with deletions for glycoproteins G and E. Firkins LD, Weigel RM, Biehl LG, Hahn EC. Am J Vet Res; 1997 Sep 01; 58(9):976-84. PubMed ID: 9285001 [Abstract] [Full Text] [Related]
13. Characterization of the pseudorabies virus-specific immunoglobulin M response and evaluation of its diagnostic use in pigs with preexisting immunity to the virus. Kimman TG. J Clin Microbiol; 1993 Sep 01; 31(9):2309-14. PubMed ID: 8408547 [Abstract] [Full Text] [Related]
14. Inactivation of glycoprotein gE and thymidine kinase or the US3-encoded protein kinase synergistically decreases in vivo replication of pseudorabies virus and the induction of protective immunity. Kimman TG, De Wind N, De Bruin T, de Visser Y, Voermans J. Virology; 1994 Dec 01; 205(2):511-8. PubMed ID: 7975253 [Abstract] [Full Text] [Related]
17. Safety of an Aujeszky's disease vaccine based on deletion mutant strain 783 which does not express thymidine kinase and glycoprotein I. van Oirschot JT, Terpstra C, Moormann RJ, Berns AJ, Gielkens AL. Vet Rec; 1990 Nov 03; 127(18):443-6. PubMed ID: 2177288 [Abstract] [Full Text] [Related]
18. Protection against pseudorabies virus infection by intranasal vaccination of newborn pigs. McCaw MB, Xu J. Am J Vet Res; 1993 Apr 03; 54(4):527-33. PubMed ID: 8387249 [Abstract] [Full Text] [Related]
20. A DNA vaccine coding for gB and gD of pseudorabies virus (suid herpes type 1) primes the immune system in the presence of maternal immunity more efficiently than conventional vaccines. van Rooij EM, Moonen-Leusen HW, de Visser YE, Middel WG, Boersma WJ, Bianchi AT. Vaccine; 2006 Feb 27; 24(9):1264-73. PubMed ID: 16289276 [Abstract] [Full Text] [Related] Page: [Next] [New Search]